18F‐Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis

…, AA Malayeri, PA Merkel, E Novakovich… - Arthritis & …, 2018 - Wiley Online Library
Objective To assess the clinical value of 18 F‐fluorodeoxyglucose ( FDG ) positron emission
tomography ( PET ) in a prospective cohort of patients with large vessel vasculitis ( LVV ) …

Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis

…, AA Bagheri, PA Merkel, E Novakovich… - Annals of the …, 2018 - ard.bmj.com
Objectives To assess agreement between interpretation of magnetic resonance angiography
(MRA) and 18 F-fluorodeoxyglucose positron emission tomography (PET) for disease …

Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis

KA Quinn, H Dashora, E Novakovich… - …, 2021 - academic.oup.com
Objectives To evaluate the time-dependent effects of tocilizumab on vascular inflammation
as measured by 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) in GCA. …

Effect of treatment on imaging, clinical, and serologic assessments of disease activity in large-vessel vasculitis

…, JS Rosenblum, AC Civelek, E Novakovich… - The Journal of …, 2020 - jrheum.org
Objective. Disease activity in large-vessel vasculitis (LVV) is traditionally assessed by clinical
and serological variables rather than vascular imaging. This study determined the effect of …

Association of 18F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis

…, T Neogi, J Marko, E Novakovich… - Arthritis & …, 2023 - Wiley Online Library
Objective To assess whether vascular activity seen on 18 F‐fluorodeoxyglucose–positron
emission tomography (FDG‐PET) scan is associated with angiographic change in large vessel …

[HTML][HTML] Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study

…, M Merideth, HN Sen, M Davis, E Novakovich… - Arthritis research & …, 2017 - Springer
Background The effect of IL-1 blocking therapy on mucocutaneous manifestations of Behçet’s
disease is incompletely understood. Methods Six patients with Behçet’s disease and …

Patterns of clinical presentation in Takayasu's arteritis

…, KJ Warrington, SR Ytterberg, E Novakovich… - Seminars in arthritis and …, 2020 - Elsevier
Objective Takayasu's arteritis (TAK) is a clinically heterogenous disease. Patterns of clinical
presentation in TAK at diagnosis have not been well described, and a “triphasic pattern” of …

Comparing semiquantitative and qualitative methods of vascular 18F-FDG PET activity measurement in large-vessel vasculitis

…, KA Quinn, H Alessi, E Novakovich… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The study rationale was to assess the performance of qualitative and semiquantitative scoring
methods for 18 F-FDG PET assessment in large-vessel vasculitis. Methods: Patients with …

Outcome measures in large vessel vasculitis: relationship between patient‐, physician‐, imaging‐, and laboratory‐based assessments

…, K Bates Gribbons, E Novakovich… - Arthritis care & …, 2020 - Wiley Online Library
Objective To assess the relationship between measures of disease assessment in patients
with large vessel vasculitis. Methods Patients with giant cell arteritis ( GCA ) or Takayasu …

[HTML][HTML] Positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis

…, AA Malayeri, PA Merkel, E Novakovich… - Arthritis & …, 2018 - ncbi.nlm.nih.gov
Objectives To assess the clinical value of 18 F-flurodeoxyglucose (FDG) positron emission
tomography (PET) in a prospective cohort of patients with large-vessel vasculitis (LVV) and …